(NP (NP-COOD (NP (NP (NN Alteration)) (PP (IN of) (NP (NP (JJ structural) (NN order)) (PP (IN of) (NP (JJ human) (NN erythrocyte) (NN ghost) (NN membrane))))) (PP (IN by) (NP (NNS glucocorticoids)))) (CC and) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (DT the) (NN glucocorticoid) (NN receptor) (NN antagonist) (NN RU) (CD 486))))) (. .))
(S (NP-SBJ-18 (JJ High-dose) (NN pulse) (NN glucocorticoid) (NN therapy)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (NP (-NONE- *-18)) (ADVP (RB successfully)) (PP (IN in) (NP (DT the) (NN clinic))) (PP (IN in) (NP (JJ severe) (JJ pathological) (NNS conditions))) (PP-TMP (IN for) (NP (QP (RB about) (CD 20)) (NNS years)))))) (. .))
(S (NP-SBJ (NP (DT The) (NN mode)) (PP (IN of) (NP (NN glucocorticoid) (NN action))) (PP-TMP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (JJ such) (NNS megadoses)))))) (VP (VBZ is) (ADJP-PRD (JJ inexplicable)) (PP-TMP (RP up) (TO to) (NP (RB now)))) (. .))
(S (NP-SBJ (PRP It)) (VP (VBZ is) (VP (VBN supposed) (SBAR (IN that) (S (NP-SBJ (DT some) (NNS effects)) (VP (MD may) (VP (VB be) (PP-PRD (JJ due) (TO to) (NP (NN membrane) (NNS alterations))))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ present) (ADJP (FW in-vitro)) (NNS experiments))) (NP-SBJ-19 (NP (DT the) (NN effect)) (PP-COOD (PP (IN of) (NP (NN dexamethasone))) (, ,) (PP (IN of) (NP (JJ further) (NNS glucocorticoids))) (, ,) (CC and) (PP (IN of) (NP (DT the) (NN glucocorticoid) (NN receptor) (NN antagonist) (NN RU) (CD 486)))) (, ,) (PP (IN on) (NP (NP (JJ structural) (NN order)) (PP (IN of) (NP (JJ human) (NN erythrocyte) (NN ghost) (NNS membranes)))))) (VP (VBD was) (VP (VBN investigated) (NP (-NONE- *-19)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG determining) (NP (NP (DT the) (JJ steady-state) (NN fluorescence) (NN anisotropy)) (PP (IN of) (NP (NP (NN diphenylhexatriene)) (PRN (-LRB- -LRB-) (NP (NN DPH)) (-RRB- -RRB-)))))))))) (. .))
(S (NP-SBJ-20 (NN Dexamethasone)) (VP (VBD was) (VP (VBN found) (S (NP-SBJ (-NONE- *-20)) (VP (TO to) (VP (VB induce) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NN membrane) (JJ structural) (NN order)))) (PP (IN at) (NP (NP (NNS concentrations)) (PP (IN of) (NP (QP (RB about) (CD 10-LRB--6-RRB-)) (NN M))))) (PP (IN in) (NP (DT a) (JJ concentration-dependent) (NN manner)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD found) (NP (NP (DT a) (NN correlation)) (PP (IN between) (NP-COOD (NP (NP (DT the) (NN uptake)) (PP (IN of) (NP (NN dexamethasone))) (PP (IN by) (NP (DT the) (NN ghost) (NNS membranes)))) (CC and) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (DT the) (JJ structural) (NN order)))))))) (. .))
(S (NP-SBJ (NP (NP (DT The) (JJ other) (NNS glucocorticoids)) (VP (VBN tested) (NP (-NONE- *)))) (, ,) (NP-COOD (NP (NN methylprednisolone)) (CC and) (NP (NN corticosterone))) (, ,)) (VP (VBD were) (ADVP (RB also)) (ADJP-PRD (JJ effective)) (PP (IN at) (NP (NP (NNS concentrations)) (PP (IN of) (NP (CD 10-LRB--5-RRB-) (NN M) (QP (CC or) (JJR greater))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD observed) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NN membrane) (JJ structural) (NN order))) (PP (IN with) (NP (NP (NN RU) (CD 486)) (PP (IN up) (TO to) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (CD 10-LRB--4-RRB-) (NN M))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NP (JJ simultaneous) (NN incubation)) (PP (IN of) (NP (NN RU) (CD 486))) (PP (IN with) (NP (NN dexamethasone)))) (VP (VBD caused) (NP (NP (DT a) (JJ distinct) (NN interference)) (PP (IN of) (NP (NN RU) (CD 486))) (PP (IN with) (NP (NN dexamethasone))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ-COOD (NP (DT the) (JJ glucocorticoid-induced) (NN membrane) (NN perturbation)) (, ,) (NP (DT the) (NN possibility) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB inhibit) (NP (PRP it)) (PP (IN by) (NP (NN RU) (CD 486))))))) (, ,) (CC and) (NP (NP (DT the) (NN inactivity)) (PP (IN of) (NP (DT the) (ADJP (RB structurally) (JJ related)) (NN progesterone)))) (, ,)) (VP (VBP refer) (PP (TO to) (NP (NP (ADJP (RB relatively) (JJ specific)) (VBG binding) (NNS sites)) (PP (IN for) (NP (DT the) (NNS glucocorticoids))) (PP (IN in) (NP (NP (DT the) (NN membrane)) (PP (IN of) (NP (NN erythrocyte) (NNS ghosts)))))))) (. .))
